MediPharm Labs (MEDIF) Short Interest Ratio & Short Volume → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free MEDIF Stock Alerts $0.06 0.00 (0.00%) (As of 04/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest MediPharm Labs Short Interest DataCurrent Short Volume1,192,800 sharesPrevious Short Volume1,169,500 sharesChange Vs. Previous Month+1.99%Dollar Volume Sold Short$75,384.96Short Interest Ratio / Days to Cover3.4Last Record DateMarch 31, 2024Today's Trading Volume48,707 sharesAverage Trading Volume109,989 sharesToday's Volume Vs. Average44% Short Selling MediPharm Labs ? Sign up to receive the latest short interest report for MediPharm Labs and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMEDIF Short Interest Over TimeMEDIF Days to Cover Over TimeMEDIF Percentage of Float Shorted Over Time Ad Gold Safe ExchangeThe “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! MediPharm Labs Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20241,192,800 shares $75,384.96 +2.0%N/A3.4 $0.06 3/15/20241,169,500 shares $56,486.85 -4.0%N/A6.5 $0.05 2/29/20241,218,200 shares $60,057.26 -1.8%N/A5 $0.05 2/15/20241,240,000 shares $63,984.00 -1.8%N/A7 $0.05 1/15/20241,237,300 shares $66,443.01 -0.9%N/A5.1 $0.05 12/31/20231,249,100 shares $60,706.26 +0.1%N/A5.3 $0.05 Get the Latest News and Ratings for MEDIF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MediPharm Labs and its competitors with MarketBeat's FREE daily newsletter. 12/15/20231,248,500 shares $59,928.00 -15.4%N/A6.1 $0.05 11/30/20231,475,900 shares $70,990.79 +14.5%N/A7.3 $0.05 11/15/20231,288,700 shares $64,821.61 -3.6%N/A4.7 $0.05 10/31/20231,337,200 shares $70,203.00 -2.6%N/A7.3 $0.05 10/15/20231,373,400 shares $71,416.80 -0.3%N/A10.3 $0.05 9/30/20231,377,200 shares $73,267.04 -1.2%N/A4.8 $0.05 9/15/20231,393,800 shares $85,718.70 -6.1%N/A4 $0.06 8/31/20231,484,200 shares $94,840.38 +8.5%N/A5.6 $0.06 8/15/20231,367,500 shares $81,092.75 +3.6%N/A3.8 $0.06 7/31/20231,319,900 shares $58,207.59 -2.3%N/A8.5 $0.04 7/15/20231,351,000 shares $63,497.00 +3.8%N/A8 $0.05 6/30/20231,302,000 shares $59,501.40 -1.7%N/A4.3 $0.05 6/15/20231,324,900 shares $66,245.00 -1.7%N/A4.6 $0.05 5/31/20231,348,100 shares $68,483.48 +2.0%N/A9.7 $0.05 5/15/20231,322,000 shares $75,354.00 -2.0%N/A19 $0.06 4/30/20231,349,200 shares $74,206.00 -16.8%N/A3.7 $0.06 4/15/20231,621,500 shares $113,505.00 +20.4%N/A2.5 $0.07 3/31/20231,346,600 shares $68,676.60 -4.2%N/A21.9 $0.05 3/15/20231,405,300 shares $74,480.90 +3.7%N/A5.6 $0.05 2/28/20231,355,300 shares $78,607.40 -3.2%N/A8.2 $0.06 2/15/20231,399,400 shares $87,462.50 +1.3%N/A12.9 $0.06 1/31/20231,381,700 shares $84,283.70 -2.5%N/A6.2 $0.06 1/15/20231,417,100 shares $76,523.40 +1.7%N/A13.3 $0.05 12/30/20221,393,500 shares $67,863.45 -3.1%N/A6.2 $0.05 12/15/20221,438,500 shares $77,679.00 -2.5%N/A11.3 $0.05 11/30/20221,475,000 shares $93,662.50 -14.5%N/A5.5 $0.06 11/15/20221,725,000 shares $109,020.00 -5.1%N/A3.9 $0.06 10/31/20221,816,900 shares $106,833.72 -0.1%N/A13.7 $0.06 10/15/20221,818,200 shares $97,364.61 -6.8%N/A9.5 $0.05 9/30/20221,951,600 shares $104,410.60 -9.8%N/A11 $0.05 9/15/20222,162,500 shares $122,276.40 -0.3%N/A23.8 $0.06 8/31/20222,168,700 shares $117,109.80 +7.7%N/A9.4 $0.05 8/15/20222,014,400 shares $136,576.32 -4.6%N/A9.9 $0.07 7/31/20222,111,200 shares $136,383.52 -12.3%N/A10.7 $0.06The “Perfect Storm” for Gold (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! MEDIF Short Interest - Frequently Asked Questions What is MediPharm Labs' current short interest? Short interest is the volume of MediPharm Labs shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 1,192,800 shares of MEDIF short. Learn More on MediPharm Labs' current short interest. What is a good short interest ratio for MediPharm Labs? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MEDIF shares currently have a short interest ratio of 3.0. Learn More on MediPharm Labs's short interest ratio. Is MediPharm Labs' short interest increasing or decreasing? MediPharm Labs saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 1,192,800 shares, an increase of 2.0% from the previous total of 1,169,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short MediPharm Labs stock? Short selling MEDIF is an investing strategy that aims to generate trading profit from MediPharm Labs as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against MediPharm Labs? A short squeeze for MediPharm Labs occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MEDIF, which in turn drives the price of the stock up even further. How often is MediPharm Labs' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MEDIF, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: TGIFF Short Squeeze CATV Short Squeeze FFNTF Short Squeeze ABSCF Short Squeeze ACRDF Short Squeeze ACRHF Short Squeeze ALEAF Short Squeeze LBTSF Short Squeeze ALVOW Short Squeeze ERBB Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:MEDIF) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIYour Money is Not SafeAmerican AlternativeHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceSHOCKING Crypto Leak…Crypto 101 MediaMy biggest AI fearParadigm Press